Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Mayer

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Child Psychology and Psychiatry, and Allied Disciplines|March 29, 2019
Commentary: Building the developmental foundations of developmental computational psychiatry: reflections on Hauser et al. (2019)Katherine E Kabotyanski, Michael D Mayer, Mahalia Prater Fahey, et al.
Clinical Pharmacology and Therapeutics|April 24, 2003
Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxilEric P Brass, Michael D Mayer, Darcy J Mulford, et al.
Journal of Chromatographic Science|May 15, 2002
Assay of TNP-470 and its two major metabolites in human plasma by high-performance liquid chromatography-mass spectrometryCarl T Whalen, Glenn D Hanson, Kathy J Putzer, et al.
Journal of Clinical Pharmacology|January 7, 2006
The effect of mild and moderate hepatic impairment on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidaseReza Khosravan, Brian A Grabowski, Michael D Mayer, et al.
American Journal of Therapeutics|January 22, 2005
Pharmacokinetics and pharmacodynamics of febuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairmentMichael D Mayer, Reza Khosravan, Laurent Vernillet, et al.
Aerospace Medicine and Human Performance|May 26, 2017
Relaxation with Immersive Natural Scenes Presented Using Virtual RealityAllison P Anderson, Michael D Mayer, Abigail M Fellows, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Child Psychology and Psychiatry, and Allied Disciplines|March 29, 2019
Commentary: Building the developmental foundations of developmental computational psychiatry: reflections on Hauser et al. (2019)Katherine E Kabotyanski, Michael D Mayer, Mahalia Prater Fahey, et al.
Clinical Pharmacology and Therapeutics|April 24, 2003
Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxilEric P Brass, Michael D Mayer, Darcy J Mulford, et al.
Journal of Chromatographic Science|May 15, 2002
Assay of TNP-470 and its two major metabolites in human plasma by high-performance liquid chromatography-mass spectrometryCarl T Whalen, Glenn D Hanson, Kathy J Putzer, et al.
Journal of Clinical Pharmacology|January 7, 2006
The effect of mild and moderate hepatic impairment on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidaseReza Khosravan, Brian A Grabowski, Michael D Mayer, et al.
American Journal of Therapeutics|January 22, 2005
Pharmacokinetics and pharmacodynamics of febuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairmentMichael D Mayer, Reza Khosravan, Laurent Vernillet, et al.
Aerospace Medicine and Human Performance|May 26, 2017
Relaxation with Immersive Natural Scenes Presented Using Virtual RealityAllison P Anderson, Michael D Mayer, Abigail M Fellows, et al.
Pageof 1